KRAS mutation status in colorectal cancer to predict response to EGFR targeted therapies: the need for a more precise definition

Detalles Bibliográficos
Autores principales: Rouleau, E, Spyratos, F, Dieumegard, B, Guinebretière, J M, Lidereau, R, Bièche, I
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2008
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2607232/
https://www.ncbi.nlm.nih.gov/pubmed/19078954
http://dx.doi.org/10.1038/sj.bjc.6604815

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2607232/
https://www.ncbi.nlm.nih.gov/pubmed/19078954
http://dx.doi.org/10.1038/sj.bjc.6604815

Ejemplares similares